- Western Digital Corporation Stock Drops 11% Despite Beating Earnings
- Sui crypto sinks to $0.67, stuck below $1.01 EMA200 level
- APPLOVIN CORPORATION : WEDBUSH CUTS TARGET PRICE TO $610 FROM $640
- INSULET CORPORATION : BERNSTEIN CUTS TARGET PRICE TO $175 FROM $200
- FLUTTER ENTERTAINMENT PLC <FLUT.N>: WEDBUSH CUTS TARGET PRICE TO $126 FROM $138
- Bed Bath & Beyond Executive Chairman and CEO Marcus Lemonis acquires common shares worth $202,592.94
- HUBSPOT, INC. <HUBS.N>: BERNSTEIN CUTS TO MARKET-PERFORM FROM OUTPERFORM; CUTS TARGET PRICE TO $220 FROM $381
- DHT forecasts Q3 spot rates booked to date at $152,700 a day for 58% of spot days
- Pasinex launches tender for 500 DMT of 46% zinc sulphide from Pinargozu mine
- CRA International declares quarterly cash dividend of $0.57 per share
- Delcath net income holds at $2.7 million in Q2 FY26; revenue rises 20.25% to $29.1 million vs Q2 FY25
- NetApp acquires VMware disaster recovery firm JetStream Software
- Theriva Biologics doses first patient in VIRAGE2 Phase 2a trial of VCN-01 for metastatic pancreatic cancer
- VivoSim Labs issues 9,896,718 shares on warrant exercises
- CRA International schedules fiscal Q2 2026 results conference call
- Hertz Q2 FY26 swings to GAAP profit of $64 million; revenue rises 10% to $2.4 billion
- Nano-X Imaging issues warrants to buy 8,000,000 shares at USD 1.15 in registered direct offering
- TXT e-solutions H1 FY26 adjusted net profit rises 32.8% to EUR 17.9 million; revenue increases 20.6% to EUR 228 million
- Chegg Sees 3Q Rev $43M-$44M >CHGG
- Edgewise net loss widens 58.74% to $57.33 million in Q2 FY26
- Praxis Precision net loss widens 17.7% to $83.72 million in Q2 FY26
- MBX Biosciences Q2 FY26 net loss widens to $37.1 million; R&D expenses rise to $31 million
- Aurinia Q2 net income climbs 74% to $37.4 million; revenue rises 19% to $83.2 million
- VivoSim regains compliance with Nasdaq $2.5 million stockholders’ equity rule
- Ralph Lauren Continues to Expect Cap Expenditures for FY27 of About 4% to 5% of Rev >RL
- Prime Medicine 3Q Loss/Shr 24c >PRME
- Prime Medicine 3Q Loss $42.1M >PRME
- Aligos Therapeutics 2Q Loss $1.5M >ALGS
- Insight Enterprises Q2 FY26 net earnings climb 65% to $77.6 million; net sales rise 15% to $2.4 billion
- Quanterix management participates in Canaccord Genuity Growth Conference fireside chat
- Establishment Labs Q2 FY26 net loss narrows to $11.7 million; revenue rises 31.7% to $67.5 million
- AquaBounty Q2 net loss narrows 52% to $1.63 million
- Helix returns to profit in Q2 FY26 with net income of $22.7 million; revenue rises 21% to $304 million vs Q2 FY25
- Burford Capital Q2 FY26 revenue drops 42% to USD 110.68 million; net income falls 91% to USD 9.48 million
- Delcath Systems 2Q Net $2.67M >DCTH
- Ralph Lauren Sees 2Q Revenue Growing About Mid-Single Digits on Constant Currency Basis, Centered Around 5% to 6% >RL
- Delcath Systems 2Q Rev $29.1M >DCTH
- Praxis Precision Med 2Q Loss/Shr $2.87 >PRAX
- Praxis Precision Med 2Q Loss $83.7M >PRAX
- Whitehawk Therapeutics 2Q Research and Development Expenses $12.9M >WHWK
- White Mountains Insurance 2Q Net $199M >WTM
- USA Today net income returns to profit at $9.13 million in Q2 FY26; revenue falls 8.3% to $536.34 million
- Zillow: US home sales rise 7% in July as pending listings slump 7.7% from June
- Pacira publishes positive two-year Phase 1 data for PCRX-201 gene therapy in knee osteoarthritis
- Whitehawk Q2 FY26 net loss narrows to $16.64 million
- Vivani Medical completes dosing in SLIM-1 Phase 1 trial of NPM-139 semaglutide implant for weight management
- Globalstar Q2 FY26 swings to net loss of $26.5 million; revenue falls 5% to $64.8 million
- LEMAITRE VASCULAR, INC. <LMAT.O>: BARRINGTON RESEARCH RAISES TO OUTPERFORM FROM MARKET PERFORM
- Ascendis Pharma posts slide presentation on achondroplasia program updates
- Kratos wins US Army contract to develop next-generation infrared seeker for Javelin missile system
- BRIEF-Chegg Q2 Revenue USD 51.849 Million
- Centrus Energy signs LEU, HALEU enrichment supply deal with X-energy
- vTv Therapeutics Q2 FY26 net loss widens to $13.1 million; R&D expenses more than doubled to $8.8 million
- BlackRock TCP Capital Q2 FY26 net investment income falls to $18.14 million; revenue drops to $40 million
- Hyliion wins USD 41.7 million U.S. Navy contract for multi-megawatt KARNO power modules
- Rallybio swings to Q2 net income of $43.67 million; operating loss narrows to $5.65 million
- SHOPIFY INC. <SHOP.TO>: ATB CORMARK CAPITAL MARKETS RAISES TARGET PRICE TO C$260 FROM C$240
- Deutz managing body member Sebastian C. Schulte buys shares worth EUR 983,089
- Quirin Privatbank reiterates Buy on Deutz, sets target price at EUR 14
- Burford Capital announces 2Q26, YTD26 financial results in Form 8-K
- Amphenol Adjusts 3Q View To Adj EPS 70c-Adj EPS 71c >APH
- Guerrilla RF Q2 FY26 operating income swings to $1 million; revenue rises 49% to $8 million
- Xunlei schedules Q2 earnings release, conference call
- ALX Oncology Q2 FY26 GAAP net loss narrows to $18 million; R&D expenses fall 27.2% to $13.1 million
- Belite Bio schedules webcast to discuss Q2 financial results
- Mira Pharma reports positive 7-day dog toxicokinetic study results for obesity drug candidate SKNY-1
- Aligos Q2 FY26 net loss narrows 91% to $1.5 million
- E.L.F. BEAUTY, INC. <ELF.N>: BERNSTEIN RAISES TARGET PRICE TO $121 FROM $113
- Tejon Ranch Q2 FY26 swings to net profit of $2.6 million; revenue rises 56.76% to $17.4 million
- BRIEF-Insight Enterprises Q2 EPS USD 2.57
- Cion Investment Net Asset Value Per Shr Was $13.57 as of June 30 >CION
- BRIEF-Delcath Systems Q2 Revenue USD 29.133 Million Vs. IBES Estimate USD 26.3 Million
- BRIEF-Ralph Lauren Q1 Revenue USD 2,000 Million Vs. IBES Estimate USD 1,867 Million
- Corbus Pharmaceuticals 2Q Loss $35M >CRBP
- Aurinia Pharmaceuticals 2Q Rev $83.2M >AUPH
- Aurinia Pharmaceuticals 2Q EPS 28c >AUPH
- MBX Biosciences 2Q Loss/Shr 78c >MBX
- Zhengye Biotechnology regains Nasdaq compliance with $1 minimum bid price rule
- Enad Global 7 to host live presentation and Q&A on Q2 interim report
- Copper 360 appoints Neal Froneman as board chair
- Douglas Elliman to host conference call on second-quarter 2026 results
- Kingsoft Cloud to release Q2 2026 results before US market open
- Digia H1 EBITA drops 16.7% to EUR 6.4 million; net sales rise 2.9% to EUR 110.7 million
- Sempra Q2 FY26 GAAP earnings rise 72.67% to $796 million
- Xtant Medical schedules Q2 results conference call
- BRIEF-Fox Q4 Revenue USD 4,210 Million Vs. IBES Estimate USD 3,643 Million
- BRIEF-ALX Oncology Q2 Basic EPS USD -0.13
- BRIEF-Edgewise Therapeutics Q2 Operating Income USD -61.943 Million
- BRIEF-Hertz Q2 Adjusted EPS USD -0.11 Vs. IBES Estimate USD -0.24
- BRIEF-Prime Medicine, Inc. Q2 EPS USD -0.24
- BRIEF-Marcus & Millichap Q2 Revenue USD 202.915 Million
- BRIEF-Praxis Precision Q2 EPS USD -2.87
- BRIEF-Tejon Ranch Q2 EPS USD 0.1
- BRIEF-Helix Energy Solutions Q2 EPS USD 0.15
- BRIEF-USA TODAY Co Inc Q2 Revenue USD 536.337 Million Vs. IBES Estimate USD 546.7 Million
- Cion Investment 2Q EPS 62c >CION
- Fox Corp. Raises Semi-Annual Dividend to 29c Vs. 28c >FOXA
- Cion Investment 2Q Net Investment Income 29c Per Shr >CION
- New spot margin trading pair — US/USDT!
- New spot margin trading pair — QUID/USDT!
